InVera Medical™ (formerly known as Venari Medical) are delighted to announce the publication of its pre-clinical feasibility study of the InVera™ minimally invasive, exclusively mechanical venous ablation device in Phlebology, an official journal of several international venous societies.
The study showed that the InVera™ device can safely achieve chronic fibrotic vein occlusion by an exclusively mechanical mechanism of action in a recognised large animal model.
Unlike venous ablation devices on the market today, the InVera™ device has a non-thermal, mechanical-only action which offers two key differentiations that may improve clinical safety and efficacy for Chronic Venous Disease patients: